Novo Nordisk Total Current Liabilities 2012-2026 | NVO

Novo Nordisk total current liabilities for the quarter ending March 31, 2026 were $35.260B, a 5.83% increase year-over-year.

  • Novo Nordisk total current liabilities for 2025 were $32.651B, a 3.52% increase from 2024.
  • Novo Nordisk total current liabilities for 2024 were $31.542B, a 28.04% increase from 2023.
  • Novo Nordisk total current liabilities for 2023 were $24.634B, a 43.85% increase from 2022.

Novo Nordisk Total Current Liabilities 2012-2026 | NVO

  • Novo Nordisk total current liabilities for 2025 were $32.651B, a 3.52% increase from 2024.
  • Novo Nordisk total current liabilities for 2024 were $31.542B, a 28.04% increase from 2023.
  • Novo Nordisk total current liabilities for 2023 were $24.634B, a 43.85% increase from 2022.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$887.6B
Johnson & Johnson (JNJ)$574.4B
AbbVie (ABBV)$367.7B
Roche Holding AG (RHHBY)$318.8B
Merck (MRK)$299.9B
Novartis AG (NVS)$294B
Pfizer (PFE)$153.1B
Sanofi (SNY)$114B
Bayer (BAYRY)$46.2B
Innoviva (INVA)$1.8B